Guardian Partners
ABBV icon

Guardian Partners’s AbbVie ABBV Stock Holding History

Guardian Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$467K Hold
1,785
– – 0.04% 161
2026
Q2 		$449K Sell
1,785
-192
-10% -$41.3K 0.04% 155
2026
Q1 		$430K Buy
1,977
+1
+0.1% +$222 0.04% 150
2025
Q4 		$429K Buy
+1,976
New +$450K 0.03% 162

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Bahl & Gaynor
Bahl & Gaynor Cincinnati, Ohio $21B AUM 23.02% 1-Year Est. Return

Guardian Partners's ABBV Position: Q3 2026 in Review

Guardian Partners held its AbbVie (ABBV) position steady in Q3 2026 at 1,785 shares worth $467K. The position accounts for 0.04% of the portfolio, ranked #161.

Guardian Partners first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 2,599 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Guardian Partners held 1,785 shares of AbbVie worth $467K as of Q3 2026.
  • Guardian Partners left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.04% of Guardian Partners's portfolio in Q3 2026, its #161 holding.
  • Guardian Partners first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 2,599 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Guardian Partners's 13F filing for Q3 2026, filed 21 Oct 2026.